Article · 13 Feb 2026
Mini reviewPublished 29 May 2024
Polymeric Caffeic Acid as an Innovative Antigen Carrier for Mucosal Vaccines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Mucosal vaccination presents a promising avenue for enhancing immune responses against pathogens, particularly those that enter the body through mucosal surfaces. However, the development of effective mucosal vaccines faces numerous challenges, including antigen stability, delivery efficiency and immune stimulation. In recent years, Polymeric Caffeic Acid (PCA) has emerged as a novel antigen carrier with remarkable potential for mucosal vaccine applications. PCA, derived from natural sources, offers several advantages, including biocompatibility, biodegradability and immunomodulatory properties. This article provides an overview of the recent advances in utilizing PCA as an antigen carrier for mucosal vaccines, highlighting its unique properties, formulation strategies and potential applications in combating infectious diseases.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kondo Yamanaka”
